For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Oncolytics Biotech, Inc (NASDAQ: ONCY) closed at $0.67 in the last session, up 4.31% from day before closing price of $0.64. In other words, the price has increased by $4.31 from its previous closing price. On the day, 0.92 million shares were traded.
Ratios:
We take a closer look at ONCY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.21 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 06, 2022, initiated with a Buy rating and assigned the stock a target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
Stock Price History:
Over the past 52 weeks, ONCY has reached a high of $1.53, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 33.03%, while the 200-Day Moving Average is calculated to be -15.60%.
Shares Statistics:
A total of 86.42M shares are outstanding, with a floating share count of 85.98M. Insiders hold about 3.20% of the company’s shares, while institutions hold 10.75% stake in the company.
